NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2023, Vol. 35 ›› Issue (增刊1): 159-164.

Previous Articles     Next Articles

Research progress on pharmacological action and clinical application of tetramethylpyrazine

CHEN Xing-yun,DONG Yong-xi,CHEN Li-na,DONG Li*   

  1. Guizhou Medical University,Gui′an New Area 550025,China
  • Online:2023-06-28 Published:2023-06-13

Abstract:

Tetramethylpyrazine is the main effective component of Ligusticum chuanxiong(family Umbelliferae),it is clinically used to treat ischemic cardiovascular and cerebrovascular diseases with good curative effect.Based on the clinical application research literature of tetramethylpyrazine in recent years,the clinical application progress and pharmacological effects of tetramethylpyrazine are reviewed for clinical reference.

Key words: tetramethylpyrazine, pharmacological action, clinical application

CLC Number: